Niacinamide Serum ODM & Private Label Manufacturing in Korea

Most actives on this site raise a formulation question first. Niacinamide raises a claim question first. The formula needs very little adjustment to move between markets, and the sentence printed on the front of the pack often has to be rewritten completely — the same formula sits in the ordinary cosmetic category in one country and in a separately assessed one in another, and the difference is usually one word. This page covers both halves: what rises alongside the concentration, and what changes when the product crosses a border.

What Is Niacinamide?

Niacinamide is a form of vitamin B3 — a small, water-soluble crystalline material supplied as a powder, which dissolves in the water phase of a formula. That single property explains most of what follows: any format with a meaningful water phase can carry it, and any format without one struggles.

Unlike several of the actives on this site, the marketing word and the label word are the same. Niacinamide is its own INCI name, so nothing has to be converted between your copy and the ingredient declaration — one common source of late label rework removed.

Two similar names cause confusion and are worth separating early:

• Nicotinamide is the same substance under an older name, not a different material.
• Nicotinic acid, also called niacin, is a different substance — the one niacinamide can slowly turn into in an acidic system, which is why the pH discussion below matters.

One more thing before the formula: the INCI name is identical across suppliers and the material is not. Grade and purity differ, and the difference shows up as odour or colour drift late in shelf life rather than in the first sample — which is why we ask for the specification and the certificate of analysis before a formulation route is chosen rather than after.

Why Brands Are Developing Niacinamide Products

Niacinamide reached general consumer awareness earlier than most actives, and under its own name rather than a marketing abbreviation. Shoppers search for it, recognise it on a pack and have an opinion about the percentage next to it. A new brand in this category is not paying to explain an ingredient. Cost per kilogram is also low compared with the biotech actives, so the material is rarely the constraint on the cost sheet — which is why niacinamide supports a full range rather than a single hero product.

Three patterns show up repeatedly in the briefs we receive:

• A hero serum built around a printed percentage. The figure on the front of the pack is the positioning, and the whole project follows from choosing it.
• A supporting active across an entire range. Niacinamide appears in the toner, the essence and the cream without being the headline in any of them.
• The claim carrier in a Korean range. A soothing or barrier product is registered for a brightening function on the strength of a listed functional active rather than of its own hero ingredient — the pattern described in centella and cica line development.

The commercial catch is that almost every brand already has a niacinamide product. Neither the ingredient nor the percentage differentiates on its own. Differentiation comes from the supporting complex, the texture, the tolerance profile and whether the claim was written for the market the product is sold into.

Product Formats We Can Develop

Water solubility keeps the format list wide. In order of how often we build them:

• Serums and ampoules — the default, and the format carrying most of the search demand. See Korean serum and ampoule manufacturing.
• Toners, essences and toner pads — comfortable, high-water systems, and the place a supporting-role level does useful work at a low cost per unit. Covered under Korean skincare manufacturing.
• Emulsions and creams — straightforward. The active goes into the water phase, so it constrains the manufacturing sequence far less than a heat-sensitive material would. See moisturiser and cream development in Korea.
• Sheet masks — the essence is a simple aqueous system and carries the active without difficulty. See Korean sheet mask manufacturing.
• Anhydrous balms, oils and sticks — the difficult case. With no water phase there is nothing to dissolve the material into, and what remains is a suspension with a gritty after-feel. Changing the format or the active is usually the better answer.

Developing a Niacinamide Product: ODM, OEM or Private Label?

Niacinamide is one of the strongest private label cases on this site. The formulation problem is well solved, good bases exist at several price points, and the category rewards a texture that works over a formula that is novel. If your differentiation is brand, packaging and channel, private label niacinamide serums will get you to market sooner and with less capital at risk.

What private label does not hand you is control over the percentage. A catalogue base has the level it has, so if your positioning depends on a percentage no existing base carries, niacinamide ODM development in Korea is the route that produces it — as it is when you want a matched range with one sensory signature, or a claim set written for a specific market.

OEM is the least common route for a first niacinamide product, because few new brands arrive owning a formula. It becomes the right answer later, when an established product moves into Korean production.

Formulation Considerations

A printed percentage is a specification, not a marketing line. The use level inside the formula and the percentage on the front of the pack are the same value, and printing it changes what it obliges you to do: every batch has to meet it, the certificate of analysis and the artwork have to agree, and the release specification needs a tolerance band that production can hold across shelf life rather than only at time zero. Settle the percentage before artwork is finalised — changing it afterwards means new artwork, scrapped printed components and, in several markets, a fresh filing.

Three things rise with the level, and cost is the smallest of them. The other two are pH management and tolerance, and behind both sits the amount of stability work the project needs. A brand asking for a higher percentage is asking for all of it, which is worth knowing before the first prototype rather than after panel feedback.

pH. Niacinamide is comfortable in a mildly acidic to neutral system. In a strongly acidic one, and across shelf life rather than at time zero, it can convert to nicotinic acid, which is associated with transient flushing in some users. None of that is visible in a fresh batch, so it is an accelerated stability question — and the reason the pH window is agreed before the supporting actives are chosen.

Vitamin C and exfoliating acids. These are usually kept apart because they prefer a different pH window from niacinamide rather than because of any single incompatibility, and a formula that accommodates both tends to serve neither well. Brands that want both generally ship two products, which is also a cleaner commercial story and an easier one to write claims for.

Compatibility elsewhere. Niacinamide sits comfortably with humectants, panthenol, ceramides, peptides and centella derivatives — see ceramide barrier cream development for the most common pairing in this category. It is less comfortable in high-electrolyte systems and with some cationic polymers.

Tolerance is a positioning decision. Higher levels attract more reported stinging and flushing from sensitive users, and whether that trade is worth making depends on who the product is for. The tolerance target belongs in the brief alongside the claim rather than emerging from panel results.

We work from four inputs when developing a niacinamide formula in Korea — target level, tolerance target, claim intent and destination market. See how to brief a Korean formulation lab for what a complete brief contains.

Packaging Considerations

Niacinamide systems are aqueous and often visually clear, so the pack carries a preservation job and a claim job at once.

• Airless pump bottles — the practical default for a serum. Minimal headspace oxygen and no finger contact, which suits a high-water system. The trade-offs are set out in airless pump versus dropper packaging.
• Dropper bottles — expected by consumers in this category. The dropper reintroduces air and contact at every use, so the preservative system has to be specified for it.
• Tubes — the sensible choice for creams and emulsions, and cost-efficient at small fill volumes.
• Jars — visually persuasive in the premium segment and the highest preservation burden, because the product is opened and touched repeatedly.
• Toner bottles and pad jars — a large surface area and headspace, which makes preservation and challenge testing the deciding constraint rather than the formula.

Two further points are specific to this ingredient. A printed percentage ties the component to the formula — if the level moves during development the printed component is scrapped, and print runs carry their own minimum separate from the fill. And clear components display colour drift honestly: slight yellowing late in shelf life is invisible in an opaque tube and obvious in clear glass. Components are qualified alongside the formula through Korean cosmetic packaging sourcing.

Claims and Regulatory Notes by Market

With niacinamide, the claim decides the category more often than the formula does. That makes this the section to read first rather than last. Orientation only — not a compliance opinion.

Start with the vocabulary. Brightening and whitening are not interchangeable in regulatory terms, however loosely English marketing uses them. Language about the appearance of an even tone describes how skin looks; language about lightening skin describes changing the skin itself, and in several markets that second sense — or the local word carrying it — names a regulated function with its own approval route. Choosing between them is a regulatory decision made while the marketing copy is written, and far cheaper to make before artwork than after.

United States. Classification turns on intended use: a product intended to affect the structure or function of the body is a drug under the FD&C Act regardless of how it is labelled, and the FDA guidance on whether a product is a cosmetic, a drug, or both is the primary reference. Appearance-based phrasing is the cosmetic register here. MoCRA registration, listing and safety substantiation obligations apply to imported product.

European Union. Regulation (EC) No 1223/2009 governs, with INCI declaration, a Product Information File, a safety assessment by a qualified assessor, an EU Responsible Person and CPNP notification. Claims must satisfy the common criteria, which call for evidential support and no implication of a medicinal effect. A printed percentage is itself a claim, and the file is expected to stand behind it.

Korea. Under the Cosmetics Act, functional cosmetics is a defined category and brightening is one of the recognised functions. A product registered for that function contains a listed functional active at the level the designation specifies, which changes the registration path rather than the formula. It is also the mechanism behind many Korean ranges whose hero ingredient is something else entirely — the functional claim belongs to the listed active, not to the marketing story.

Japan. Japan splits the category in a way Korea does not: ordinary cosmetics are notified, while quasi-drugs require item-by-item approval using an approved active at an approved level. Brightening and whitening positioning generally moves a product into the quasi-drug category, so a product that is notified in Korea can need item-by-item approval in Japan on the strength of its claim set alone. Reframing the claim is sometimes cheaper than pursuing approval — see selling Korean-made cosmetics in Japan.

Taiwan. Taiwan used to sort cosmetics into two tiers, with skin-lightening products among those carrying a licence the rest did not need. That tier was retired, and every cosmetic now takes the same route: registration with the TFDA before supply, with a Product Information File standing behind it. Much of the guidance still circulating online describes the old structure, which is a common reason a Taiwan plan is built on a timeline that no longer exists — see selling Korean-made cosmetics in Taiwan.

MOQ and Development Timeline

We do not publish minimum order figures, because a single number would be wrong for almost every brief that reaches us. On niacinamide projects the active is rarely what sets the minimum. What does:

• Format and fill volume. A 30 ml serum and a 200 ml toner have different economics at the same batch size.
• Packaging. Stock components order in far smaller quantities than custom tooling or custom decoration, and the component minimum usually exceeds the fill minimum.
• A printed percentage. Committing to a figure ties the artwork and the printed component to the release specification, which removes the option of adjusting the level later.
• The supporting complex. The expensive material in a niacinamide formula is usually not the niacinamide, and a specialty raw material with its own supplier minimum can set the project floor.
• Markets. Where two destinations read the claim differently, they may need separate artwork and separate filings, which changes whether one production run can serve both.

How cosmetic MOQ is actually determined sets out how these interact and what to change if the first quote comes back above your budget. On timeline, niacinamide development is among the more predictable — the formulation work is well understood, and the fixed block is stability and challenge testing, which cannot be compressed by paying more. Where a percentage is printed, artwork cannot be finalised until the release specification is settled, which puts that decision earlier in the schedule than brands expect.

Frequently Asked Questions

What percentage of niacinamide should my product contain?

Start from three things rather than from the figure itself: the claim you intend to make, the tolerance target for the people you are selling to, and the market you are selling into. A higher percentage is a commitment rather than an achievement — every batch has to meet it, and it pulls pH management, tolerance and packaging along with it. We would rather settle the level before artwork than reprint components afterwards.

Can niacinamide and vitamin C go in the same product?

They can be formulated together, and they usually should not be. The two prefer different pH windows, so a single formula that accommodates both tends to serve neither well. Most brands ship two products instead, which is easier to formulate, easier to substantiate and a clearer story on the shelf.

Can I use the word brightening in every market?

No, and the word matters more than the formula behind it. Language about the appearance of an even tone generally sits in the cosmetic register. Language about lightening skin generally does not, and in several markets it names a regulated function with its own approval route. Agree the claim set per market before packaging artwork is finalised — the same discipline described in what clean beauty claims mean and what they cost.

Will my niacinamide serum be a quasi-drug in Japan?

It depends on the claim rather than on the formula. Japan notifies ordinary cosmetics and approves quasi-drugs item by item, and brightening and whitening positioning generally moves a product into the second group, where an approved active at an approved level is required. The same bulk can therefore take two different routes depending only on what the pack says, so decide whether to reframe the claim or pursue approval before the Japanese artwork is drawn.

Does a niacinamide product need a special licence in Taiwan?

Not any more. Taiwan used to place skin-lightening products in a separate tier that carried its own licence, and that tier was retired — every cosmetic now takes the same registration before supply, with a Product Information File behind it. A great deal of guidance describing the old two-tier system is still online, so a quoted licence lead time for a Taiwanese brightening product is a sign that whoever quoted it is working from stale material.

Is private label good enough for a niacinamide product?

Often yes, and more often than brands expect. Mature bases exist across price tiers with stability data already in place, and the category rewards a texture that works. Private label makes sense when your differentiation is brand, packaging and channel. ODM makes sense when the percentage, the supporting complex or a specific market's claim set is the thing you are actually selling.

This page is general information for manufacturing planning. It is not legal or regulatory advice, it has no legal effect, and no rights can be derived from it. Requirements change by market and over time — before acting on anything here, confirm the current position with the authority concerned or with qualified counsel.